Cogent Biosciences COGT
NASDAQ COGT
$34.76 -0.19 (-0.54%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cogent Biosciences (COGT) Interest Coverage Ratio (2025 - 2026)

Cogent Biosciences (COGT) posted quarterly Interest Coverage Ratio of 15.18 for Q1 2026, up 99.92% year-over-year from 7.59 in Q1 2025, and up 80.75% quarter-over-quarter from 78.84 in Q4 2025.

Analysis

Cogent Biosciences (COGT) Interest Coverage Ratio (2025 - 2026) Analysis & Trends

Cogent Biosciences (COGT) has reported Interest Coverage Ratio for 10 consecutive years, with 15.18 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest Coverage Ratio rose 99.92% year-over-year to 15.18; the TTM figure through Mar 2026 stood at 53.03 (up 99.93% YoY), while the FY2025 annual figure was 0.45, up 64.66% from the prior year.
  • Interest Coverage Ratio advanced to 15.18 in Q1 2026 per COGT's latest filing, from 78.84 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.92 in Q2 2022 and bottomed at 18733.25 in Q1 2025.
  • Historically, Interest Coverage Ratio has averaged 1426.33 across 5 years, with a median of 78.84 in 2025.
  • Annual changes were most pronounced in 2023 — Interest Coverage Ratio slumped 48721.25% — and 2026, when it soared 99.92%.
  • Cogent Biosciences' Interest Coverage Ratio stood at 111.88 in 2022, then soared by 56.04% to 49.18 in 2023, then soared by 59.07% to 20.13 in 2024, then tumbled by 291.65% to 78.84 in 2025, then surged by 80.75% to 15.18 in 2026.
  • Business Quant data shows COGT's Interest Coverage Ratio at 15.18 in Q1 2026, 78.84 in Q4 2025, and 14.5 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Cogent Biosciences 5.94 Bn 5.94 Bn - -84.34
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -84.34
Mar 31, 2026 -85.41
Dec 31, 2025 -77.19
Sep 30, 2025 -57.13
Jun 30, 2025 -240.71